These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1722994)

  • 1. The successful treatment of two cases of severe aplastic anaemia with granulocyte-colony stimulating factor and cyclosporine A.
    Bertrand Y; Amri F; Capdeville R; Ffrench M; Philippe N
    Br J Haematol; 1991 Dec; 79(4):648-9. PubMed ID: 1722994
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor.
    Otsubo H; Kaito K; Sekita T; Shimada T; Kobayashi M; Hosoya T
    Int J Hematol; 1998 Dec; 68(4):445-8. PubMed ID: 9885444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interleukin-3 on responsiveness to granulocyte-colony-stimulating factor in severe aplastic anemia.
    Geissler K; Forstinger C; Kalhs P; Knöbl P; Kier P; Kyrle P; Lechner K
    Ann Intern Med; 1992 Aug; 117(3):223-5. PubMed ID: 1377461
    [No Abstract]   [Full Text] [Related]  

  • 4. Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia.
    Gluckman E; Rokicka-Milewska R; Hann I; Nikiforakis E; Tavakoli F; Cohen-Scali S; Bacigalupo A;
    Br J Haematol; 2002 Dec; 119(4):1075-82. PubMed ID: 12472591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia.
    Nawata J; Toyoda Y; Nisihira H; Honda K; Kigasawa H; Nagao T
    Eur J Pediatr; 1994 May; 153(5):325-7. PubMed ID: 7518392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined antithymocyte globulin. cyclosporin. methylprednisolone and granulocyte colony-stimulating factor are effective in a patient with hepatitis-associated severe aplastic anemia].
    Kanakura M; Mihara H; Wakabayashi M; Tajima E; Hiramatsu A; Sato A; Imamura A; Miwa H; Kato Y; Nitta M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91(3):1036-8. PubMed ID: 11985078
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group.
    Locasciulli A; Arcese W; Locatelli F; Di Bona E; Bacigalupo A;
    Lancet; 2001 Jan; 357(9249):43-4. PubMed ID: 11197365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of immunosuppression in aplastic anaemia.
    Marsh JC
    Acta Haematol; 2000; 103(1):26-32. PubMed ID: 10705156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-thymocyte globulin, cyclosporin A and granulocyte colony-stimulating factor for severe aplastic anaemia complicating paediatric liver transplantation.
    Hadzic N; Layton M; Heaton ND; Rela M; Baker AJ; Mieli-Vergani G
    Eur J Pediatr; 1998 Feb; 157(2):107-8. PubMed ID: 9504782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anaemia.
    Bessho M; Toyoda A; Itoh Y; Sakata T; Kawai N; Jinnai I; Saito M; Hirashima K
    Br J Haematol; 1992 Mar; 80(3):409-11. PubMed ID: 1374630
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in aplastic anemia.
    Imamura M; Kobayashi M; Kobayashi S; Yoshida K; Mikuni C; Ishikawa Y; Matsumoto S; Sakamaki S; Niitsu Y; Hinoda Y
    Am J Hematol; 1995 Jan; 48(1):29-33. PubMed ID: 7530405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine and recombinant granulocyte colony-stimulating factor in severe aplastic anemia.
    Kojima S; Fukuda M; Miyajima Y; Matsuyama T
    N Engl J Med; 1990 Sep; 323(13):920-1. PubMed ID: 1697647
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 15. Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor.
    Escobar-Morreale HF; Bravo P; García-Robles R; García-Laraña J; de la Calle H; Sancho JM
    Thyroid; 1997 Feb; 7(1):67-70. PubMed ID: 9086574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids.
    Jakucs J; Pocsay G
    J Endocrinol Invest; 2006 Jan; 29(1):74-7. PubMed ID: 16553037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor.
    Matsuo Y; Iwanaga M; Mori H; Yoshida S; Kawaguchi Y; Yakata Y; Murata K; Nagai K; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M
    Int J Hematol; 2000 Jul; 72(1):37-43. PubMed ID: 10979207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of recombinant human G-CSF. Aplastic anemia (AA) and myelodysplastic syndromes (MDS).
    Yoshida Y; Asano S; Hirashima K; Takaku F
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():349-52. PubMed ID: 1284304
    [No Abstract]   [Full Text] [Related]  

  • 20. Highly fluorescent reticulocyte count predicts haemopoietic recovery after immunosuppression for severe aplastic anaemia.
    Sica S; Sora' F; Laurenti L; Piccirillo N; Salutari P; Chiusolo P; D'Onofrio G; Leone G
    Clin Lab Haematol; 1999 Dec; 21(6):387-9. PubMed ID: 10671990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.